Form D — Dermata Therapeutics, Inc.
0001493152-25-004861 · filed Feb 4, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Other Technology filings
Offering
- Industry
- Other Technology
- Exemptions
- 06b
- Reported offering amount
- $2,550,000
- Reported amount sold
- $2,550,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Dermata Therapeutics, Inc.
- CIK
- 1853816
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 3525 DEL MAR HEIGHTS RD.
SAN DIEGO, CA 92130 - Phone
- 858-223-0882
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Gerald Proehl · Executive OfficerSan Diego, CA Find on LinkedIn ↗
-
Kyri K. Van Hoose · Executive OfficerSan Diego, CA Find on LinkedIn ↗
-
Christopher J. Nardo · Executive OfficerSan Diego, CA Find on LinkedIn ↗
-
Maria Bedoya Toro Munera · Executive OfficerSan Diego, CA Find on LinkedIn ↗
-
David Hale · DirectorSan Diego, CA Find on LinkedIn ↗
-
Wendell Wierenga · DirectorSan Diego, CA Find on LinkedIn ↗
-
Andrew Sandler · DirectorSan Diego, CA Find on LinkedIn ↗
-
Brittany Bradrick · DirectorSan Diego, CA Find on LinkedIn ↗
-
Kathleen Scott · DirectorSan Diego, CA Find on LinkedIn ↗
-
Mary Fisher · DirectorSan Diego, CA Find on LinkedIn ↗
-
Steven J. Mento · DirectorSan Diego, CA Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗